GoodRx could seek up to $969M in IPO
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.
The 5-year partnership has helped grant 450 wishes across the country for kids with critical illnesses.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.